Position in BMY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$14,072,301
-$787,433 QoQ
Shares Held
244,226
-0.3% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#334
of 2,505 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOKF, NA holds $220,983,153 across 10 Drug Manufacturers - General names. BMY ranks #7 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,087 | $61,275,284 | |
| 2 | ABBV |
AbbVie Inc.
|
194,942 | $49,055,203 | |
| 3 | JNJ |
Johnson & Johnson
|
142,681 | $36,236,693 | |
| 4 | AMGN |
Amgen Inc
|
67,477 | $24,434,770 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
136,461 | $17,240,482 | |
| 6 | MRK |
Merck & Co., Inc.
|
114,907 | $14,765,549 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
244,226 | $14,072,301 | |
| 8 | PFE |
Pfizer Inc
|
82,045 | $1,975,643 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,072,301 | 244,226 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $14,859,734 | 245,008 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $12,762,581 | 236,607 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $11,932,558 | 264,580 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,401,680 | 181,501 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,054,042 | 115,659 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,827,319 | 103,029 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,254,972 | 101,565 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,986,173 | 120,062 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $7,773,490 | 143,343 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,979,000 | 116,527 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,443,397 | 128,246 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,830,969 | 153,729 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $12,290,603 | 177,328 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $11,234,056 | 156,137 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $11,250,133 | 158,252 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $12,459,524 | 161,812 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $13,590,809 | 186,099 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $10,981,642 | 176,129 | Shares | Other | 2022-03-11 | |
| 2021-09-30 | $11,063,132 | 186,972 | Shares | Other | 2021-11-10 | |
| 2021-03-31 | $12,847,396 | 203,507 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $13,869,101 | 223,587 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $19,725,681 | 327,180 | Shares | Other | 2020-10-30 | |
| 2020-06-30 | $15,903,694 | 270,471 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $13,250,122 | 237,713 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||